Source: Annual Congress 2008 - Rationale of self-education in asthma therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ulitina, Y. Ilkovich, N. Shklyarevich (St.Petersburg, Russian Federation). Cost-effectiveness analysis of asthma treatment strategies. Eur Respir J 2008; 32: Suppl. 52, 4422

Member's Comments

No comment yet.

Related content which might interest you: Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Cost-effectiveness analysis of a Home-based disease management intervention for patients with severe COPD alongside the COMET study. Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Cost analysis for patients with severe asthma receiving omalizumab treatment Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Cost-effectiveness of a Brazilian program for severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK Source: ERJ Open Res, 7 (1) 00480-2020; 10.1183/23120541.00480-2020 Year: 2021 Primary asthma prevention amongst children — A cost-effectiveness analysis in a decision-analytic framework Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Cost-utility analysis of a Home-based disease management intervention for patients with severe COPD in the COMET study. Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Cost-effectiveness of eNO measurements in chronic asthma management Source: Eur Respir J 2007; 30: Suppl. 51, 193s Year: 2007 Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Source: Eur Respir J 2010; 35: 532-539 Year: 2010 The therapeutic strategies in severe and very severe COPD: a cost-efficacy analysis in Italy Source: Eur Respir J 2006; 28: Suppl. 50, 31s Year: 2006 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD Source: Annual Congress 2010 - Smoking related disorders and smoking cessation Year: 2010 Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019